(2026). Elevated sclerostin levels in cerebrospinal fluid are associated with cognitive impairment in the Alzheimer's disease continuum. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Elevated Sclerostin Levels in Cerebrospinal Fluid Are Associated with Cognitive Impairment in the Alzheimer's Disease Continuum."
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Elevated Sclerostin Levels in Cerebrospinal Fluid Are Associated with Cognitive Impairment in the Alzheimer's Disease Continuum."
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.